Age (Years) |
66.9±13.2 |
Genere, Male |
387 (74.7%) |
IHD |
173 (33.3%) |
PTCA |
99 (19.1%) |
CABG |
35 (6.7%) |
Valvular Desease |
46 (8.9%) |
AF at Implant |
58 (11.2%) |
AF History |
126 (24.3%) |
LVEF |
29.6±11.7 |
CRT-D device |
201 (38.8%) |
SCD for Secondary Prevention |
108 (20.8%) |
COPD |
148 (28.5%) |
CKD |
55 (10.6%) |
Hypertension |
275 (53.0%) |
Diabetes |
110 (21.2%) |
Beta-blockers |
454 (87.4%) |
ACEI’s |
225 (43.4%) |
Angiotensin Receptor Blockers, Sartanics |
126 (24.3%) |
Valsartan/sacubitril, Entresto
|
97 (18.7%) |
Diuretics |
410 (79.0%) |
NOACs |
223 (42.9%) |